These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2052979)

  • 21. Bacteremia caused by gram-negative bacilli.
    Ries KM; Kaye D
    Pa Med; 1972 Mar; 75(3):91-4. PubMed ID: 5042627
    [No Abstract]   [Full Text] [Related]  

  • 22. Enterobacter cloacae bacteremia: clinical analysis of 41 cases.
    Fung CP; Wang LS; Juang YC; Liu CY; Cheng DL
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Oct; 42(4):297-304. PubMed ID: 3242768
    [No Abstract]   [Full Text] [Related]  

  • 23. Septic shock after intracervical laminaria insertion.
    Lin SY; Cheng WF; Su YN; Chen CA; Lee CN
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):76-8. PubMed ID: 17272216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endocarditis and bacteremia caused by Enterobacter agglomerans].
    Muñoz Sanz A; García de la Llana F; Fernández Mora G; Blanco Palenciano J
    Med Clin (Barc); 1991 Mar; 96(11):436-7. PubMed ID: 2046434
    [No Abstract]   [Full Text] [Related]  

  • 25. Ceftriaxone in treatment of serious infections. Septicemia.
    Foster MT
    Hosp Pract (Off Ed); 1991 Sep; 26 Suppl 5():43-7; discussion 62-3. PubMed ID: 1918222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yersinia Enterocolitica Bacteremia in a Chronic, Mildly Iron-Overloaded Dialysis Patient.
    Mergenhagen KA; Telesz AL
    Ann Pharmacother; 2011 Feb; 45(2):e14. PubMed ID: 21266629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of ceftriaxone in urinary and respiratory tract infections].
    Papierkowski A; Pietraszek-Mamcarz J; Kozłowska T; Górnicka G; Emeryk A
    Pol Tyg Lek; 1990 Apr 2-9; 45(14-15):300-2. PubMed ID: 2235713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serratia marcescens bacteremia.
    Wong WW; Wang LS; Cheng DL; Lin SJ; Chin TD; Hinthorn DR; O'Connor MC; Huang WK
    J Formos Med Assoc; 1991 Jan; 90(1):88-93. PubMed ID: 1679115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Septic pylephlebitis associated with Enterobacter cloacae septicemia].
    Amezyane T; Abouzahir A; El Kharrass A; Bassou D; Fatihi J; Hammi S; Mahassin F; Ghafir D; Ohayon V
    J Mal Vasc; 2010 Feb; 35(1):31-4. PubMed ID: 19879707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enterobacter sakazakii bacteraemia with multiple splenic abscesses in a 75-year-old woman: a case report.
    Gosney M
    Age Ageing; 2008 Mar; 37(2):236-7. PubMed ID: 18349020
    [No Abstract]   [Full Text] [Related]  

  • 33. Resistance in Enterobacteriaceae: results of a multicenter surveillance study, 1995-2000.
    Friedland I; Stinson L; Ikaiddi M; Harm S; Woods GL
    Infect Control Hosp Epidemiol; 2003 Aug; 24(8):607-12. PubMed ID: 12940583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
    Ye Y; Li JB; Ye DQ; Jiang ZJ
    Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime.
    Grohs P; Kernéis S; Sabatier B; Lavollay M; Carbonnelle E; Rostane H; Souty C; Meyer G; Gutmann L; Mainardi JL
    J Antimicrob Chemother; 2014 Mar; 69(3):786-9. PubMed ID: 24159154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patients.
    de Lastours V; Goulenok T; Guérin F; Jacquier H; Eyma C; Chau F; Cattoir V; Fantin B
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):417-421. PubMed ID: 29318461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cluster of neonatal infections in Jerusalem due to unusual biochemical variant of Enterobacter sakazakii.
    Block C; Peleg O; Minster N; Bar-Oz B; Simhon A; Arad I; Shapiro M
    Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):613-6. PubMed ID: 12226694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carriage of Staphylococcus aureus and of gram-negative bacilli resistant to third-generation cephalosporins in cirrhotic patients: a prospective assessment of hospital-acquired infections.
    Dupeyron C; Campillo SB; Mangeney N; Richardet JP; Leluan G
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):427-32. PubMed ID: 11583211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enterobacter bacteremia in the community hospital.
    Haddy RI; Cecil ML; Norris LL; Markert RJ
    J Fam Pract; 1991 Jun; 32(6):601-6. PubMed ID: 2040885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful medical management of a patient with multiple hepatic abscesses due to Edwardsiella tarda.
    Zighelboim J; Williams TW; Bradshaw MW; Harris RL
    Clin Infect Dis; 1992 Jan; 14(1):117-20. PubMed ID: 1571414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.